Abstract | RATIONALE: OBJECTIVES: METHODS: In this double-blind cross-over study, each subject was exposed to both active cannabis ( THC) and placebo. RESULTS: Compared to placebo, cannabis administration was associated with significant increases in plasma levels of ghrelin and leptin, and decreases in PYY, but did not significantly influence insulin levels. CONCLUSION:
|
Authors | Patricia K Riggs, Florin Vaida, Steven S Rossi, Linda S Sorkin, Ben Gouaux, Igor Grant, Ronald J Ellis |
Journal | Brain research
(Brain Res)
Vol. 1431
Pg. 46-52
(Jan 11 2012)
ISSN: 1872-6240 [Electronic] Netherlands |
PMID | 22133305
(Publication Type: Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2011 Elsevier B.V. All rights reserved. |
Chemical References |
- Analgesics, Non-Narcotic
- Ghrelin
- Hormones
- Leptin
- Peptide YY
- Dronabinol
|
Topics |
- Adult
- Analgesics, Non-Narcotic
(therapeutic use)
- Appetite
(drug effects)
- Double-Blind Method
- Dronabinol
(therapeutic use)
- Ghrelin
(blood)
- HIV Infections
(blood, complications, drug therapy)
- Hormones
(blood)
- Humans
- Leptin
(blood)
- Male
- Middle Aged
- Neuralgia
(drug therapy, etiology)
- Peptide YY
(blood)
- Pilot Projects
|